BioLargo, Inc.
BLGO
$0.16
$0.00-1.82%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 617.00K | 1.10M | 2.78M | 3.27M | 3.66M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 617.00K | 1.10M | 2.78M | 3.27M | 3.66M |
| Cost of Revenue | 489.00K | 731.00K | 1.36M | 1.78M | 1.91M |
| Gross Profit | 128.00K | 372.00K | 1.42M | 1.49M | 1.75M |
| SG&A Expenses | 3.47M | 6.94M | 2.69M | 2.56M | 2.58M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.61M | 8.28M | 4.58M | 5.13M | 5.27M |
| Operating Income | -4.00M | -7.18M | -1.80M | -1.86M | -1.62M |
| Income Before Tax | -4.14M | -7.24M | -1.88M | -1.92M | -1.73M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.14M | -7.24M | -1.88M | -1.92M | -1.73M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 1.19M | 765.00K | 690.00K | 766.00K | 718.00K |
| Net Income | -2.95M | -6.48M | -1.19M | -1.16M | -1.01M |
| EBIT | -4.00M | -7.18M | -1.80M | -1.86M | -1.62M |
| EBITDA | -3.96M | -7.15M | -1.78M | -1.80M | -1.58M |
| EPS Basic | -0.01 | -0.02 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | -0.01 | -0.02 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 314.29M | 308.97M | 303.20M | 301.27M | 301.22M |
| Average Diluted Shares Outstanding | 314.29M | 308.97M | 303.20M | 301.27M | 301.22M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |